Promoter holding
64.27%
VP
Vellanova Pharmaceuticals Ltd - Due diligence report
A 360° intelligence report on Vellanova Pharmaceuticals Ltd: trust score, financial health, credit view, compliance, directors, growth and d…
VP
Vellanova Pharmaceuticals Ltd
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Vellanova Pharmaceuticals Ltd — 360° Intelligence Report
Generated from MCA filings & public records52/100
Trust Score
Moderate
Vellanova Pharmaceuticals Ltd is assessed as Moderate with a Trust Score of 52/100. Vellanova Pharmaceuticals Ltd is a public limited indian non-government company incorporated in 1986, operating in the Chemicals sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and an unassessed financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Vellanova Pharmaceuticals Ltd snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
52/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
30/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
No processed financialsFinancial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: N/A No Data
- Financial statements needed for a credit view.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 30/100 Caution Indicated
- Company status is "Strike Off" - not Active.
- Last balance sheet is for Mar 2010 - filings overdue.
05
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ARATI SANJAYA SARAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DHIRAJLAL CHUNILAL MEHTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANJAYA CHANDRABHUSHAN SARAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- DHIRAJLAL CHUNILAL MEHTA has DIN status "Disqualified by RoC u/s 164(2)".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
06
Ownership & Group Intelligence
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth N/A · Distress 55
Growth signals & trust indicators
Operating for 39+ years.
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (30/100).
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence44/100
Caution indicated
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- No financials on record - ask for audited statements.
Banker assessment27/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- No filed financials - rely on banking statements and GST data.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
Investor view32/100
Limited indicators at present
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Request management accounts - public filings insufficient.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 6 events30 Sep 2010
Last AGM held
Annual general meeting
31 Mar 2010
Latest balance sheet
Filed with ROC
25 Jun 2007
Director appointed
DHIRAJLAL CHUNILAL MEHTA (Director)
Director appointed
SANJAYA CHANDRABHUSHAN SARAN (Director)
04 Sep 1986
Incorporated
Registered with Roc Mumbai
Director appointed
ARATI SANJAYA SARAN (Director)
10
Key Observations
Auto-generated from the data above3 active director(s) / partner(s); review board churn before relying on management continuity.
Peer companies will appear here as our matching engine processes this industry.
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Vellanova Pharmaceuticals Ltd before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Vellanova Pharmaceuticals Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Vellanova Pharmaceuticals Ltd - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Caution indicated. Trust score 52/100, distress signals and MSME payment-delay disclosures - know whether Vellanova Pharmaceuticals Ltd pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Vellanova Pharmaceuticals Ltd - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Vellanova Pharmaceuticals Ltd an active company?
Vellanova Pharmaceuticals Ltd has MCA status “Strike Off” with a compliance score of 30/100 (Caution Indicated).
Is Vellanova Pharmaceuticals Ltd financially healthy?
Processed financial statements are not yet available for Vellanova Pharmaceuticals Ltd, so its financial health is unassessed.
Should I do business with Vellanova Pharmaceuticals Ltd?
Its overall Trust Score is 52/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Vellanova Pharmaceuticals Ltd?
See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.
Does Vellanova Pharmaceuticals Ltd have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Vellanova Pharmaceuticals Ltd up to date with its ROC filings?
Last balance sheet is for Mar 2010 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).
Is it risky to lend to Vellanova Pharmaceuticals Ltd?
Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
